Virtus Investment Advisers, Inc. Roivant Sciences Ltd. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 38,744 shares of ROIV stock, worth $448,268. This represents 0.15% of its overall portfolio holdings.
Number of Shares
38,744
Previous 30,219
28.21%
Holding current value
$448,268
Previous $304,000
43.42%
% of portfolio
0.15%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding ROIV
# of Institutions
351Shares Held
500MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$761 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$716 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$532 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.3MShares$455 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$416 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.15B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...